Filed Aug 11, 2026Period of report Aug 11, 20260001104659-26-094228
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 11, 2026
Common StockF1F2
28,800
$14.9092
$429.38K
1,201,814
Direct
Filing footnotes · 2
F1The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026. The Rule 10b5-1 trading plan was terminated on August 11, 2026.
F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.66 to $15.16, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Filed Jun 8, 2026Period of report Jun 5, 20260001104659-26-071506
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJun 8, 2026
Common StockF2
23,214
$15.4412
$358.45K
67,894
Direct
Filing footnotes · 3
F1Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis.
F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $15.48, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F31/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026.
Filed Jun 8, 2026Period of report Jun 4, 20260001104659-26-071509
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJun 4, 2026
Common StockF1
169,427
$16.2724
$2.76M
109,850
Direct
Filing footnotes · 1
F1The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.05 to $16.70, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Filed Mar 17, 2026Period of report Mar 14, 20260001104659-26-029720
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 16, 2026
Common StockF2
2,014
$8.00
$16.11K
109,719
Direct
Filing footnotes · 3
F1Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027.
F2Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
F31/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026.
Filed Mar 17, 2026Period of report Mar 14, 20260001104659-26-029718
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 16, 2026
Common StockF2
3,235
$8.00
$25.88K
103,697
Direct
Filing footnotes · 3
F1Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027.
F2Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
F31/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026.
Filed Mar 16, 2026Period of report Mar 12, 20260001104659-26-028775
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 16, 2026
Common StockF4
2,743
$8.00
$21.94K
280,371
Direct
SaleMar 12, 2026
Common StockF1F2
38,700
$7.7619
$300.39K
255,701
Direct
Filing footnotes · 6
F1The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4.
F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.725 to $7.83, inclusive.
F3Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027.
F4Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
F51/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016.
F61/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026.
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.